WO2019230871A1 - Composite material and bioimplant - Google Patents
Composite material and bioimplant Download PDFInfo
- Publication number
- WO2019230871A1 WO2019230871A1 PCT/JP2019/021484 JP2019021484W WO2019230871A1 WO 2019230871 A1 WO2019230871 A1 WO 2019230871A1 JP 2019021484 W JP2019021484 W JP 2019021484W WO 2019230871 A1 WO2019230871 A1 WO 2019230871A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composite material
- phase
- region
- material according
- titanium
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
- A61L27/427—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of other specific inorganic materials not covered by A61L27/422 or A61L27/425
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C13/00—Dental prostheses; Making same
- A61C13/08—Artificial teeth; Making same
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
- A61C8/0013—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating
- A61C8/0015—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating being a conversion layer, e.g. oxide layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/32—Joints for the hip
- A61F2/34—Acetabular cups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/32—Joints for the hip
- A61F2/36—Femoral heads ; Femoral endoprostheses
- A61F2/3662—Femoral shafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/58—Preparations specially adapted for dental root treatment specially adapted for dental implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/84—Preparations for artificial teeth, for filling teeth or for capping teeth comprising metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/06—Titanium or titanium alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C2201/00—Material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/32—Joints for the hip
- A61F2/36—Femoral heads ; Femoral endoprostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
Definitions
- the present disclosure relates to composite materials and biological implants.
- Patent Document 1 Metal materials in which fluorine ions are implanted on the surface are known (see, for example, Patent Document 1 and Non-Patent Document 1).
- the composite material according to one embodiment has a crystal phase of titanium fluoride and a metal crystal phase of titanium.
- the crystalline phase of titanium fluoride exists in the first region located away from the surface in the depth direction.
- a biological implant according to an embodiment includes the composite material according to the embodiment.
- FIG. 1 is a schematic view showing a composite material according to an embodiment.
- FIG. 2 is an example of a biological implant according to an embodiment.
- FIG. 3 is a graph showing measurement results of fluorine concentration in the examples.
- FIG. 4 is a graph showing the measurement results of hardness in Examples and Comparative Examples.
- FIG. 1 is a schematic view showing a composite material according to an embodiment.
- the cross section of the part containing the surface of a composite material is expanded and shown.
- the composite material 1 contains titanium (Ti) and fluorine (F), and includes a titanium fluoride crystal phase 2 (hereinafter sometimes referred to as “crystal phase 2”) and a titanium metal crystal phase 3 (hereinafter referred to as “crystal phase 2”). It may be referred to as “metal crystal phase 3”).
- a titanium fluoride crystal phase 2 hereinafter sometimes referred to as “crystal phase 2”
- a titanium metal crystal phase 3 hereinafter referred to as “crystal phase 2”. It may be referred to as “metal crystal phase 3”).
- titanium fluoride which is a compound of titanium and fluorine exists in a crystalline state.
- metal crystal phase 3 titanium exists in a crystal state constituted by metal bonds.
- the composite material 1 contains fluorine and has the crystal phase 2 as described above, it is possible to exhibit antibacterial properties due to fluorine. Moreover, since the composite material 1 has a large hardness, it is possible to exhibit excellent wear resistance and the like. The reason why the composite material 1 has a large hardness is estimated as follows.
- the bond between titanium and fluorine in titanium fluoride is a covalent bond. Therefore, the crystal phase 2 functions as an obstacle to transition that moves through the metal crystal phase 3. Therefore, when the composite material 1 has the crystal phase 2, the amount of energy required for the movement of transition increases, and as a result, the hardness of the composite material 1 increases. Note that as the fluorine concentration in the composite material 1 increases, the proportion of the crystal phase 2 tends to increase.
- titanium fluoride examples include TiF (titanium fluoride), TiF 2 (titanium difluoride), TiF 3 (titanium trifluoride), TiF 4 (titanium tetrafluoride), TiOF (titanium oxyfluoride), and TiOF 2.
- TiF titanium fluoride
- TiF 2 titanium difluoride
- TiF 3 titanium trifluoride
- TiF 4 titanium tetrafluoride
- TiOF titanium oxyfluoride
- TiOF 2 titanium oxyfluoride
- TiOF 2 titanium oxyfluoride
- Examples of methods for measuring the crystal structure include a transmission electron microscope (hereinafter sometimes referred to as “TEM”) and X-ray diffraction (hereinafter referred to as “XRD”). ) Or X-ray photoelectron spectroscopy (X-ray Photoelectron Spectroscopy: hereinafter referred to as “XPS”).
- TEM transmission electron microscope
- XRD X-ray diffraction
- XPS X-ray photoelectron spectroscopy
- the composite material 1 may include a region (first region) 12 including the surface 11 of the composite material 1 and having a predetermined thickness in the depth direction from the surface 11.
- the first region 12 is a composite phase of titanium and fluorine.
- the fluorine concentration in the first region 12 may be 1 ppm or more.
- the thickness T of the first region 12 is, for example, 30 to 800 nm.
- the lower limit and the upper limit are included.
- the numerical range is 30 to 800 nm
- the lower limit is 30 nm or more and the upper limit is 800 nm or less.
- the crystal phase 2 may be located in the first region 12.
- the antibacterial property due to the fluorine of the titanium fluoride is enhanced, and the hardness of the surface 11 and the vicinity thereof can be increased.
- the crystal phase 2 may be located in a region having a depth of 20 to 200 nm from the surface 11. The depth may be determined based on the surface 11.
- the metal crystal phase 3 may have a first phase 31 (fluorine-containing phase) containing fluorine.
- the metal crystal phase 3 may have the first phase 31 containing fluorine in the crystal lattice of titanium.
- fluorine may be introduced as an interstitial element in the crystal lattice of titanium. If the metal crystal phase 3 has the first phase 31, the hardness of the composite material 1 can be further increased. The reason for this is presumed as follows.
- the first phase 31 fluorine atoms enter the space in the titanium crystal lattice constituted by metal bonds. Thereby, lattice distortion corresponding to the size of the invading fluorine atom occurs in the titanium crystal.
- the deformation of the crystal lattice of titanium is caused by the movement of transition, which is a defect of the crystal lattice. If the crystal lattice of titanium is distorted by the intrusion of fluorine atoms, the mobility of transition decreases, and as a result, the hardness of the composite material 1 increases. Therefore, if the metal crystal phase 3 has the first phase 31, the first phase 31 contributes to the hardness of the composite material 1 in addition to the crystal phase 2, so that the hardness of the composite material 1 is increased. Can do. Moreover, when the fluorine concentration in the composite material 1 is decreased, the proportion of the first phase 31 tends to increase.
- the first phase 31 may be located in the first region 12.
- the first region 12 where the first phase 31 is located is the same as the first region 12 where the crystal phase 2 is located. This also applies to the first region 12 where the second phase 32 described later is located, the first region 12 where the maximum value of fluorine concentration is located, and the first region 12 where the maximum value of hardness is located. That is, the first regions 12 in the description of each configuration are all the same.
- the metal crystal phase 3 may further have a second phase 32 (fluorine-free phase) that does not contain fluorine and is located inward of the first phase 31.
- a second phase 32 fluorine-free phase
- the portion including the first phase 31 located closer to the surface 11 than the second phase 32 is less likely to be damaged.
- the second phase 32 has higher toughness than the first phase 31 due to the fact that it does not contain fluorine. Therefore, when an impact is applied to the surface 11, the impact can be mitigated by the second phase 32 having relatively high toughness. As a result, the portion including the first phase 31 located on the surface 11 side with respect to the second phase 32 is less likely to be damaged.
- the second phase 32 being located inward of the first phase 31 means that the second phase 32 is located farther from the surface 11 than the first phase 31.
- Inward means inside the composite material 1 with respect to the surface 11. In other words, inward means the direction in which the depth increases in the composite material 1.
- the phrase “not containing fluorine” means a state that does not substantially contain fluorine and is not substantially affected by fluorine. Specifically, when the fluorine concentration is less than 1 ppm, it may be determined that no fluorine is contained.
- the second phase 32 may be located inward of the first region 12.
- the second region 32 having relatively high toughness makes it difficult for the first region 12 located closer to the surface 11 than the second phase 32 to be damaged.
- the composite material 1 may further include a region (second region) 13 located inward of the first region 12.
- the second region may be a region containing titanium and not containing fluorine.
- the second phase 32 may be located in the second region.
- the second region 13 may be in contact with the first region 12. That is, the first region 12 and the second region 13 may be continuous regions in the composite material 1.
- the metal crystal phase 3 may contain, for example, a titanium-based metal.
- the titanium-based metal include pure titanium or a titanium alloy. Pure titanium includes, for example, C.I. P. Examples include industrial pure titanium such as two types of titanium.
- the titanium alloy is an alloy whose parent phase is titanium.
- the composite material 1 may further have an amorphous phase 4 (amorphous phase) containing titanium and fluorine.
- amorphous phase 4 amorphous phase
- the composite material 1 is hardly damaged by the high toughness of the amorphous phase 4.
- the amorphous phase 4 may be located in the first region 12. When satisfying such a configuration, the first region 12 is hardly damaged by the high toughness of the amorphous phase 4.
- the composite material 1 may further have a mixed phase 5 containing an amorphous phase 4, a crystal phase 2, and a metal crystal phase 3 (first phase 31).
- the mixed phase 5 is located in the first region 12.
- a plurality of amorphous phases 4, crystal phases 2, and metal crystal phases 3 are mixed.
- the material characteristics of the composite material 1 in the first region 12 are characteristics corresponding to the proportion of each phase. Specifically, it becomes the characteristic which averaged the material characteristic of each phase to contain, or the characteristic close
- the fluorine concentration may be a maximum value inward of the surface 11 (see FIG. 3).
- the surface 11 having a relatively large fluorine concentration is likely to be exposed, so that antibacterial properties are easily exhibited over a long period of time.
- the fluorine concentration may increase from the surface 11 inward and reach a maximum value (see FIG. 3). In other words, as the depth increases, the fluorine concentration may increase and reach a maximum value.
- the composite material 1 can adjust the time which exhibits antibacterial performance by adjusting distribution of fluorine concentration.
- the maximum value of the fluorine concentration may be located in the first region 12. When satisfying such a configuration, the maximum value of the fluorine concentration is located near the surface 11, so that antibacterial properties are enhanced.
- the maximum value of the fluorine concentration may be located closer to the surface 11 than the central portion 12a in the thickness direction A of the first region 12 (see FIGS. 1 and 3). When satisfying such a configuration, the maximum value of the fluorine concentration is located near the surface 11, so that antibacterial properties are enhanced.
- the concentration in fluorine concentration is atomic concentration.
- the fluorine concentration is the number of fluorine atoms per unit volume relative to the sum of the ideal number of titanium atoms per unit volume and the number of fluorine atoms.
- Examples of the method for measuring the fluorine concentration include secondary ion mass spectrometry (Secondary / Ion / Mass / Spectrometry: hereinafter sometimes referred to as “SIMS”), XPS, and the like.
- SIMS secondary ion mass spectrometry
- XPS XPS
- the maximum value of the fluorine concentration is, for example, 10 to 80 atomic%.
- the fluorine concentration in the region less than 5 nm deep from the surface 11 is, for example, 0.5 to 20 atomic%.
- the fluorine concentration in the region having a depth of 5 nm or more and less than 20 nm is, for example, 2 to 30 atomic%.
- the fluorine concentration in the region having a depth of 20 nm or more and less than 50 nm is, for example, 5 to 80 atomic%.
- the fluorine concentration in the region having a depth of 50 nm or more and 100 nm or less is, for example, 2 to 80 atomic%.
- the hardness of the composite material 1 may be a maximum value inward of the surface 11 (see FIG. 4). When such a configuration is satisfied, when the new surface 11 is exposed due to wear or the like, the surface 11 having a relatively large hardness is likely to be exposed, and thus the possibility that the surface 11 has a large hardness over a long period of time increases. .
- the surface 11 in the description of hardness is the same as the surface 11 in the description of fluorine concentration described above.
- the hardness may increase from the surface 11 inward and reach a maximum value (see FIG. 4). In other words, as the depth increases, the hardness may increase and reach a maximum value.
- a maximum value see FIG. 4
- the new surface 11 is exposed due to wear or the like, the surface 11 having a relatively large hardness is exposed, so that the surface 11 has a large hardness over a long period of time.
- the hardness may increase as it goes inward from the surface 11 and reaches a maximum value, and then may decrease as it goes further inward (see FIG. 4).
- the composite material 1 may be configured such that the change in hardness is moderate inside. According to this, since the generation of local stress can be reduced as compared with a configuration in which the hardness inside the composite material 1 changes abruptly, the possibility that the first region 12 peels can be reduced. it can.
- the maximum value of hardness may be located in the first region 12. When satisfying such a configuration, since the maximum hardness value is located near the surface 11, the hardness of the surface 11 and the vicinity thereof can be increased.
- the maximum value of hardness may be located closer to the surface 11 than the central portion 12a in the thickness direction A of the first region 12 (see FIGS. 1 and 4). When satisfying such a configuration, since the maximum hardness value is located near the surface 11, the hardness of the surface 11 and the vicinity thereof can be increased.
- the maximum value of hardness may be located closer to the surface 11 than the maximum value of fluorine concentration (see FIGS. 3 and 4).
- the hardness of the portion located near the surface 11 is relatively larger than the maximum value of the fluorine concentration. Therefore, the part located closer to the surface 11 than the maximum value of the fluorine concentration is less likely to be damaged by abrasion or the like, and can exhibit antibacterial properties over a long period of time.
- the hardness is, for example, 3 to 10 GPa.
- the maximum value of hardness is, for example, 5 to 10 GPa.
- the hardness is indentation hardness and indicates the difficulty of deformation when the surface 11 is deformed.
- the hardness is calculated from the indentation depth when the indenter is pushed into the surface 11 and the required force.
- Specific examples of the hardness measurement method include a nanoindentation method (ISO 14577 compliant).
- the composite material 1 may further include an oxide film (not shown) located on the outermost surface.
- the surface 11 of the composite material 1 consists of the surface of an oxide film.
- the thickness of the oxide film is, for example, 2 to 5 nm.
- the composition of the oxide film include TiO 2 (titanium dioxide).
- the oxide film may contain fluorine.
- the oxide film is formed by, for example, oxidation treatment. Examples of the oxidation treatment include natural oxidation, heat treatment, oxygen plasma treatment, immersion in an acid solution, or anodic oxidation.
- the titanium content may be greater than the fluorine content.
- the composite material 1 may contain titanium as a main component.
- the main component is a component that is most contained in the composite material 1 by mass ratio.
- a titanium-based metal You may wash
- an organic solvent may be used for cleaning.
- the organic solvent include ethanol or acetone.
- the exemplified organic solvents may be used as a mixture.
- the cleaning may be performed by applying ultrasonic waves.
- the titanium-based metal after cleaning may be vacuum-dried in a desiccator, for example.
- fluorine ions are implanted into the surface of the titanium-based metal to obtain the composite material 1.
- fluorine ion implantation conditions include the following conditions. Implant energy: greater than 30 keV and less than 80 keV Implant dose: 1 ⁇ 10 16 to 5 ⁇ 10 17 atoms / cm 2 (atom / cm 2 )
- the obtained composite material 1 may be washed as necessary.
- the conditions for cleaning include the same conditions as exemplified for the titanium-based metal described above.
- the composite material 1 after washing may be vacuum-dried in a desiccator, for example.
- the case where the composite material 1 is obtained by fluorine ion implantation has been described as an example.
- the method for manufacturing the composite material 1 is not limited to this, and the composite material 1 is obtained. As long as other methods are available, other methods than fluorine ion implantation may be employed.
- FIG. 2 is a schematic view showing the appearance of a dental implant according to an embodiment.
- the dental implant 100 includes a fixture 101, an abutment 102 attached to the end of the fixture 101, and an artificial tooth 103 attached to the fixture 101 via the abutment 102.
- each of the fixture 101, the abutment 102, and the artificial tooth 103 includes the composite material 1.
- the composite material 1 has antibacterial properties and a large hardness, the dental implant 100 can suppress bacterial growth, such as brushing, repeated use, or cleaning. It is possible to exhibit excellent durability against.
- each of the fixture 101, the abutment 102, and the artificial tooth 103 may be composed of only the composite material 1. These may be partially composed of the composite material 1 and the remaining portion may be composed of a material other than the composite material 1. Further, at least one of the fixture 101, the abutment 102, and the artificial tooth 103 may include the composite material 1, and the other member may include a material other than the composite material 1. According to the above configuration, the growth of bacteria on the implant surface is suppressed. For example, since the fixture 101 and the abutment 102 are used in an oxygen-deficient environment, it can be expected to suppress the growth of anaerobic bacteria.
- the composite material 1 may be appropriately used for the fixture 101, the abutment 102, and the artificial tooth 103 according to the bacterial species whose growth is to be suppressed and the necessary antibacterial performance.
- the dental implant 100 may be configured such that the first region 12 is located on the surfaces of the fixture 101, the abutment 102, and the artificial tooth 103. Further, for example, the dental implant 100 may be configured such that the first region 12 is positioned at each joint location of the fixture 101, the abutment 102, and the artificial tooth 103. This also applies to other members other than the living body implant and the living body implant described later.
- this indication is not limited to the embodiment mentioned above, and it cannot be overemphasized that it may be arbitrary, unless it deviates from the gist of this indication. .
- the biological implant is a dental implant
- the biological implant is not limited thereto.
- the living body implant may be an implant made of a living body metal such as titanium.
- Other biological implants include, for example, artificial joints such as femoral stems or acetabular shells, and spinal surgical implants such as spinal fusion instrumentation.
- the composite material 1 is used for a biological implant.
- the composite material 1 is not limited to use for a biological implant. That is, the composite material 1 may be used as a material for members that require antibacterial properties and high hardness. Other members include, for example, orthodontic wires, surgical instruments, injection needles, glasses frames, dishes, food factory lines, water bottle taps, kitchen knives, toilets, Washlets (registered trademark), faucets or water and sewage pipes Etc.
- Test piece C.I. P. Pure titanium with a thickness of 1 mm made of two types of titanium
- test piece described above was formed into a disk shape having a diameter of 14 mm and a thickness of 1 mm, and then ultrasonically washed with ethanol and acetone, and vacuum dried in a desiccator. And the fluorine ion was inject
- Fluorine ion implantation conditions are as follows.
- the obtained composite material 1 was ultrasonically washed with ethanol and acetone, vacuum-dried in a desiccator, and then used for evaluation.
- Comparative Example 1 was the same test piece as in Example 1 and Example 2 in which fluorine ions were not implanted.
- FIG. 3 is a graph showing the measurement results of fluorine concentration in Example 1 and Example 2.
- the fluorine concentrations of Example 1 and Example 2 were measured by XPS and SIMS. Specifically, the fluorine concentration was determined by XPS in a region where the fluorine concentration was relatively large and exceeded the SIMS measurement range, and the fluorine concentration was determined by SIMS in other regions. Specifically, the fluorine concentration was determined by SIMS in the range where the fluorine concentration was up to 10 atomic%. Moreover, the fluorine concentration was calculated
- FIG. 3 shows only the measurement results at a depth of 0 to 200 nm.
- the depth of 0 nm indicates the surface 11 of the composite material 1. This also applies to FIG. 4 described later.
- the measurement conditions for XPS and SIMS are as follows.
- Example 1 From the measurement results, it was revealed that in Example 1, the maximum value of the fluorine concentration is located at a depth of 90 nm. The maximum fluorine concentration of Example 1 was 63 atomic%. In Example 2, it was revealed that the maximum value of the fluorine concentration is located at a depth of 46 nm. The maximum value of the fluorine concentration in Example 2 was 11 atomic%.
- FIG. 4 is a graph showing the measurement results of hardness in Example 1, Example 2, and Comparative Example 1.
- Hardness was measured by a nanoindentation method (ISO 14577 compliant). Here, the measurement was performed at a depth of 0 to 1000 nm. FIG. 4 shows only the measurement results at a depth of 0 to 500 nm.
- the measurement conditions of hardness are as follows. Measuring device: “Nanoindenter XP” manufactured by MTS Systems Measurement mode: Continuous stiffness measurement Indentation depth: 1000 nm maximum Hardness unit: Vickers hardness
- Example 1 From the measurement results, it was revealed that in Example 1, the maximum hardness value is located at a depth of 70 nm.
- the maximum hardness value of Example 1 was 5 GPa.
- Example 2 it became clear that the maximum value of hardness is located at a depth of 20 nm.
- the maximum hardness value of Example 2 was 7 GPa.
- the crystal structure was evaluated by TEM, XRD and XPS.
- the first region 12 is determined from the thickness T of the first region 12 described above, and the region located inward of the first region 12 is defined as the second region. .
- XRD X 'Pert PRO-MRD
- PANalytical Tube CuK ⁇ Incident angle: 0.5 ° Measurement range: 10 to 120 °
- XPS measurement conditions are the same as the fluorine concentration described above.
- Example 1 the first phase 31 was confirmed in the first region 12.
- the crystal phase 2 was confirmed more than the first phase 31.
- the first phase 31 was confirmed more than the crystal phase 2.
- the amorphous phase 4 and the mixed phase 5 were confirmed in the first region 12.
- Example 1 peaks attributable to TiF 3 , TiF 4 and F—TiO 2 were obtained. Further, in Example 1, a peak attributed to the Ti—F—Ti bond was obtained, but this peak is considered to be attributable to titanium fluoride crystals. Otherwise, the state shown in FIG. 1 was confirmed.
- Antibacterial properties were measured by a film adhesion test using staphylococcus aureus (according to JIS Z 2801).
- Example 1 As a result of measurement, in Example 1, the number of viable bacteria was below the detection limit. Moreover, the antibacterial activity value of Example 1 was 3.2. Therefore, it was revealed that Example 1 has an antibacterial effect.
Landscapes
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Ceramic Engineering (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
- Dental Preparations (AREA)
- Prostheses (AREA)
- Dental Prosthetics (AREA)
- Physical Vapour Deposition (AREA)
Abstract
Description
以下、一実施形態に係る複合材料について、図面を用いて詳細に説明する。但し、以下で参照する図は、説明の便宜上、実施形態を説明する上で必要な構成のみを簡略化して示したものである。したがって、一実施形態に係る複合材料は、参照する図に示されていない任意の構成を備え得る。また、図中の構成の寸法は、実際の構成の寸法および寸法比率などを忠実に表したものではない。これらの点は、後述する生体インプラントにおいても同様である。 <Composite material>
Hereinafter, a composite material according to an embodiment will be described in detail with reference to the drawings. However, for convenience of explanation, the drawings referred to below show only a configuration necessary for describing the embodiment in a simplified manner. Thus, a composite material according to one embodiment may have any configuration not shown in the referenced figures. In addition, the dimensions of the configuration in the drawing do not faithfully represent the dimensions and size ratio of the actual configuration. These points are the same in the biological implant described later.
次に、一実施形態に係るに係る複合材料の製造方法について、上述した複合材料1を得る場合を例にとって、詳細に説明する。 <Production method of composite material>
Next, the manufacturing method of the composite material according to the embodiment will be described in detail by taking as an example the case of obtaining the
注入エネルギー:30keVよりも大きく80keV以下
注入ドーズ:1×1016~5×1017原子/cm2(atom/cm2) Next, fluorine ions are implanted into the surface of the titanium-based metal to obtain the
Implant energy: greater than 30 keV and less than 80 keV Implant dose: 1 × 10 16 to 5 × 10 17 atoms / cm 2 (atom / cm 2 )
次に、一実施形態に係る生体インプラントについて、図面を用いて詳細に説明する。なお、本実施形態では、生体インプラントの例として、歯科インプラントについて説明する。 <Biological implant>
Next, the biological implant which concerns on one Embodiment is demonstrated in detail using drawing. In this embodiment, a dental implant will be described as an example of a biological implant.
<複合材料の作製>
まず、以下に示す試験片を準備した。
試験片:C.P.2種チタンからなる厚さ1mmの純チタン [Example 1 and Example 2]
<Production of composite material>
First, the following test pieces were prepared.
Test piece: C.I. P. Pure titanium with a thickness of 1 mm made of two types of titanium
(実施例1)
注入エネルギー:40keV
注入ドーズ:5×1017原子/cm2
(実施例2)
注入エネルギー:40keV
注入ドーズ:5×1016原子/cm2 Fluorine ion implantation conditions are as follows.
Example 1
Injection energy: 40 keV
Implantation dose: 5 × 10 17 atoms / cm 2
(Example 2)
Injection energy: 40 keV
Implantation dose: 5 × 10 16 atoms / cm 2
実施例1および実施例2と同じ試験片であってフッ素イオンを注入しなかったものを比較例1とした。 [Comparative Example 1]
Comparative Example 1 was the same test piece as in Example 1 and Example 2 in which fluorine ions were not implanted.
実施例1および実施例2の複合材料1について、フッ素濃度、硬度および結晶構造を測定した。また、実施例1の複合材料1については、抗菌性を測定した。比較例1については、硬度および抗菌性を測定した。 <Evaluation>
For the
実施例1および実施例2のフッ素濃度は、XPSおよびSIMSによって測定した。具体的には、フッ素濃度が比較的大きくてSIMSの測定範囲を超える領域はXPSよってフッ素濃度を求め、それ以外の領域はSIMSによってフッ素濃度を求めた。具体的には、フッ素濃度が10原子%までの範囲はSIMSによってフッ素濃度を求めた。また、フッ素濃度が10原子%以上の範囲は、XPSによってフッ素濃度を求めた。ここで、XPSの測定は、深さ0~200nmで実施し、SIMSの測定は、深さ0~900nmで実施した。なお、図3には、深さ0~200nmの測定結果のみを示した。また、図3において、深さ0nmは、複合材料1の表面11を示す。この点は、後述する図4においても同様である。XPSおよびSIMSのそれぞれの測定条件は、以下のとおりである。 (Fluorine concentration)
The fluorine concentrations of Example 1 and Example 2 were measured by XPS and SIMS. Specifically, the fluorine concentration was determined by XPS in a region where the fluorine concentration was relatively large and exceeded the SIMS measurement range, and the fluorine concentration was determined by SIMS in other regions. Specifically, the fluorine concentration was determined by SIMS in the range where the fluorine concentration was up to 10 atomic%. Moreover, the fluorine concentration was calculated | required by XPS in the range whose fluorine concentration is 10 atomic% or more. Here, the XPS measurement was performed at a depth of 0 to 200 nm, and the SIMS measurement was performed at a depth of 0 to 900 nm. FIG. 3 shows only the measurement results at a depth of 0 to 200 nm. In FIG. 3, the depth of 0 nm indicates the
分析装置:ULVAC-PHI社製のX線光電子分光分析装置「PHI Quantera II」
X線源:モノクロAlKα
スパッタリングイオン:Ar+
加速電圧:4kV (XPS measurement conditions)
Analyzer: X-ray photoelectron spectrometer “PHI Quantera II” manufactured by ULVAC-PHI
X-ray source: Monochrome AlKα
Sputtering ion: Ar +
Acceleration voltage: 4 kV
分析装置:ULVAC-PHI社製の二次イオン質量分析装置「D-SIMS 6650」
一次イオン種:Cs+
二次イオン極性:Negative
加速電圧:2kV
ビーム電流:25nA
電荷補償:なし
ラスターサイズ:400μm (SIMS measurement conditions)
Analyzer: Secondary ion mass spectrometer “D-SIMS 6650” manufactured by ULVAC-PHI
Primary ion species: Cs +
Secondary ion polarity: Negative
Acceleration voltage: 2 kV
Beam current: 25 nA
Charge compensation: None Raster size: 400 μm
(第1領域の厚みT)
実施例1:740nm
実施例2:390nm From the depth of 0 nm (surface 11) to the depth at which the fluorine concentration becomes 1 ppm was defined as the
(Thickness T of the first region)
Example 1: 740 nm
Example 2: 390 nm
硬度は、ナノインデンテーション法(ISO 14577準拠)によって測定した。ここで、測定は、深さ0~1000nmで実施した。なお、図4には、深さ0~500nmの測定結果のみを示した。 (hardness)
Hardness was measured by a nanoindentation method (ISO 14577 compliant). Here, the measurement was performed at a depth of 0 to 1000 nm. FIG. 4 shows only the measurement results at a depth of 0 to 500 nm.
測定装置:MTSシステムズ社製の「ナノインデンターXP」
測定モード:連続剛性測定
押込み深さ:最大1000nm
硬度単位:ビッカース硬度 The measurement conditions of hardness are as follows.
Measuring device: “Nanoindenter XP” manufactured by MTS Systems
Measurement mode: Continuous stiffness measurement Indentation depth: 1000 nm maximum
Hardness unit: Vickers hardness
結晶構造は、TEM、XRDおよびXPSによって評価した。なお、TEM、XRDおよびXPSの各測定では、上述した第1領域12の厚みTから第1領域12を判断し、第1領域12よりも内方に位置している領域を第2領域とした。 (Crystal structure)
The crystal structure was evaluated by TEM, XRD and XPS. In each measurement of TEM, XRD, and XPS, the
分析装置:FEI社製の透過型電子顕微鏡「Talos F200X」
加速電圧:200kV
ビーム電流値:150pA
測定場所:複合材料1を厚み方向に切断した断面 The measurement conditions of TEM are as follows.
Analyzer: Transmission electron microscope “Talos F200X” manufactured by FEI
Accelerating voltage: 200kV
Beam current value: 150 pA
Measurement location: cross section of
分析装置:PANalytical社製の「X’ Pert PRO-MRD」
管球:CuKα
入射角度:0.5°
測定範囲:10~120° The measurement conditions of XRD are as follows.
Analyzer: “X 'Pert PRO-MRD” manufactured by PANalytical
Tube: CuKα
Incident angle: 0.5 °
Measurement range: 10 to 120 °
抗菌性は、黄色ブドウ球菌を使用したフィルム密着試験(JIS Z 2801準拠)によって測定した。 (Antibacterial)
Antibacterial properties were measured by a film adhesion test using staphylococcus aureus (according to JIS Z 2801).
付着生菌数(CFUs)
実施例1:<10(検出限界以下)
比較例1:17667 The measurement results are as follows.
Adherent viable count (CFUs)
Example 1: <10 (below detection limit)
Comparative Example 1: 17667
2・・・チタンフッ化物の結晶相
3・・・チタンの金属結晶相
31・・・第1相
32・・・第2相
4・・・非晶質相
5・・・混合相
11・・・表面
12・・・第1領域
12a・・・中央部
T・・・厚み
A・・・厚み方向
13・・・第2領域
100・・・歯科インプラント
101・・・フィクスチャー
102・・・アバットメント
103・・・人工歯 DESCRIPTION OF
Claims (19)
- チタンフッ化物の結晶相と、チタンの金属結晶相と、を有し、
前記チタンフッ化物の結晶相は、表面から深さ方向に離れて位置する第1領域に存在する、複合材料。 Having a crystal phase of titanium fluoride and a metal crystal phase of titanium,
The titanium fluoride crystal phase is a composite material present in a first region located away from the surface in the depth direction. - 前記チタンフッ化物は、TiOF2である、請求項1に記載の複合材料。 The composite material according to claim 1, wherein the titanium fluoride is TiOF 2 .
- 前記金属結晶相は、フッ素を含む第1相を有する、請求項1または2に記載の複合材料。 The composite material according to claim 1 or 2, wherein the metal crystal phase has a first phase containing fluorine.
- 前記第1相は、前記第1領域に位置している、請求項3に記載の複合材料。 The composite material according to claim 3, wherein the first phase is located in the first region.
- 前記金属結晶相は、前記第1相よりも内方に位置する第2相、をさらに有し、
前記第2相は、フッ素を含まない、請求項3または4に記載の複合材料。 The metal crystal phase further includes a second phase located inward of the first phase;
The composite material according to claim 3 or 4, wherein the second phase does not contain fluorine. - 前記第2相は、前記第1領域よりも内方に位置している、請求項5に記載の複合材料。 The composite material according to claim 5, wherein the second phase is located inward of the first region.
- チタンおよびフッ素を含む非晶質相、をさらに有する、請求項1~6のいずれかに記載の複合材料。 The composite material according to any one of claims 1 to 6, further comprising an amorphous phase containing titanium and fluorine.
- 前記非晶質相、前記チタンフッ化物の結晶相、および前記金属結晶相の混合相、をさらに有する、請求項7に記載の複合材料。 The composite material according to claim 7, further comprising a mixed phase of the amorphous phase, the crystal phase of the titanium fluoride, and the metal crystal phase.
- フッ素濃度は、表面よりも内方において最大値を示す、請求項1~8のいずれかに記載の複合材料。 9. The composite material according to claim 1, wherein the fluorine concentration shows a maximum value inward from the surface.
- 前記フッ素濃度は、前記表面から内方に向かうにつれて大きくなって最大値に至っている、請求項9に記載の複合材料。 The composite material according to claim 9, wherein the fluorine concentration increases from the surface inward and reaches a maximum value.
- 前記フッ素濃度は、前記第1領域内で最大値に至っている、請求項9または10に記載の複合材料。 The composite material according to claim 9 or 10, wherein the fluorine concentration reaches a maximum value in the first region.
- 前記フッ素濃度は、前記第1領域の深さ方向の中央部よりも前記表面の側で最大値に至っている、請求項11に記載の複合材料。 The composite material according to claim 11, wherein the fluorine concentration reaches a maximum value on the surface side with respect to a central portion in the depth direction of the first region.
- 硬度は、表面よりも内方において最大値を示す、請求項1~12のいずれかに記載の複合材料。 The composite material according to any one of claims 1 to 12, wherein the hardness shows a maximum value inward from the surface.
- 前記硬度は、前記表面から内方に向かうにつれて大きくなって最大値に至っている、請求項13に記載の複合材料。 The composite material according to claim 13, wherein the hardness increases from the surface inward and reaches a maximum value.
- 前記硬度は、前記第1領域内で最大値に至っている、請求項13または14に記載の複合材料。 The composite material according to claim 13 or 14, wherein the hardness reaches a maximum value in the first region.
- 前記硬度は、前記第1領域の深さ方向の中央部よりも前記表面の側で最大値に至っている、請求項15に記載の複合材料。 The composite material according to claim 15, wherein the hardness reaches a maximum value on the surface side with respect to a central portion in a depth direction of the first region.
- 硬度は、フッ素濃度が最大値を示す位置よりも表面の側で最大値を示す、請求項1~16のいずれかに記載の複合材料。 The composite material according to any one of claims 1 to 16, wherein the hardness shows a maximum value on the surface side from a position where the fluorine concentration shows a maximum value.
- 生体インプラント用である、請求項1~17のいずれかに記載の複合材料。 The composite material according to any one of claims 1 to 17, which is used for biological implants.
- 請求項1~18のいずれかに記載の複合材料を含む、生体インプラント。 A biological implant comprising the composite material according to any one of claims 1 to 18.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19811092.6A EP3804768A4 (en) | 2018-06-01 | 2019-05-30 | Composite material and bioimplant |
JP2020522583A JP7155259B2 (en) | 2018-06-01 | 2019-05-30 | Composites and bioimplants |
CN201980034963.4A CN112188903A (en) | 2018-06-01 | 2019-05-30 | Composite material and bioimplant |
AU2019279208A AU2019279208B2 (en) | 2018-06-01 | 2019-05-30 | Composite material and bioimplant |
US17/058,063 US20210196862A1 (en) | 2018-06-01 | 2019-05-30 | Composite material and bioimplant |
JP2022160717A JP7400049B2 (en) | 2018-06-01 | 2022-10-05 | Composite material manufacturing method |
JP2023205780A JP2024028859A (en) | 2018-06-01 | 2023-12-06 | Composite material and bioimplant |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018-106267 | 2018-06-01 | ||
JP2018106267 | 2018-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019230871A1 true WO2019230871A1 (en) | 2019-12-05 |
Family
ID=68698885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2019/021484 WO2019230871A1 (en) | 2018-06-01 | 2019-05-30 | Composite material and bioimplant |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210196862A1 (en) |
EP (1) | EP3804768A4 (en) |
JP (3) | JP7155259B2 (en) |
CN (1) | CN112188903A (en) |
AU (1) | AU2019279208B2 (en) |
WO (1) | WO2019230871A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022130981A1 (en) * | 2020-12-15 | 2022-06-23 | 京セラ株式会社 | Composite material, method for manufacturing same, and biological implant |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002332569A (en) * | 2001-05-11 | 2002-11-22 | Ion Engineering Research Institute Corp | SURFACE MODIFYING METHOD FOR IMPARTING HIGH TEMPERATURE OXIDATION RESISTANCE TO Ti-Al BASED ALLOY |
JP2005533551A (en) * | 2002-07-19 | 2005-11-10 | アストラ・テック・アクチエボラーグ | Methods for treating implants and implant surfaces |
JP4568396B2 (en) | 2000-03-01 | 2010-10-27 | 株式会社イオンテクノセンター | Surface treatment method of metal material and fluorination mold |
JP2017101275A (en) * | 2015-12-01 | 2017-06-08 | 京セラメディカル株式会社 | Titanium material and living body implant |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19628459A1 (en) * | 1996-07-15 | 1998-01-29 | Siemens Ag | Semiconductor device with low contact resistance to highly doped areas |
JP2004000504A (en) | 2002-04-09 | 2004-01-08 | Techno Network Shikoku Co Ltd | Intraoral appliance and ion implantation method to intraoral appliance |
DE202009018006U1 (en) * | 2009-05-13 | 2011-01-20 | Renkel, Manfred | Implant made of an intermetallic titanium aluminide alloy |
CN107773782A (en) | 2016-08-24 | 2018-03-09 | 上海双申医疗器械股份有限公司 | It is a kind of to put forward high purity titanium and the method for titanium alloy surface cytocompatibility and biocidal property |
CN106637121B (en) * | 2016-10-19 | 2019-04-12 | 中国科学院上海硅酸盐研究所慈溪生物材料表面工程中心 | A kind of medical titanium metal alkyl materials and its manufacturing method |
-
2019
- 2019-05-30 EP EP19811092.6A patent/EP3804768A4/en active Pending
- 2019-05-30 AU AU2019279208A patent/AU2019279208B2/en active Active
- 2019-05-30 JP JP2020522583A patent/JP7155259B2/en active Active
- 2019-05-30 US US17/058,063 patent/US20210196862A1/en active Pending
- 2019-05-30 WO PCT/JP2019/021484 patent/WO2019230871A1/en unknown
- 2019-05-30 CN CN201980034963.4A patent/CN112188903A/en active Pending
-
2022
- 2022-10-05 JP JP2022160717A patent/JP7400049B2/en active Active
-
2023
- 2023-12-06 JP JP2023205780A patent/JP2024028859A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4568396B2 (en) | 2000-03-01 | 2010-10-27 | 株式会社イオンテクノセンター | Surface treatment method of metal material and fluorination mold |
JP2002332569A (en) * | 2001-05-11 | 2002-11-22 | Ion Engineering Research Institute Corp | SURFACE MODIFYING METHOD FOR IMPARTING HIGH TEMPERATURE OXIDATION RESISTANCE TO Ti-Al BASED ALLOY |
JP2005533551A (en) * | 2002-07-19 | 2005-11-10 | アストラ・テック・アクチエボラーグ | Methods for treating implants and implant surfaces |
JP2017101275A (en) * | 2015-12-01 | 2017-06-08 | 京セラメディカル株式会社 | Titanium material and living body implant |
Non-Patent Citations (2)
Title |
---|
M. YOSHINARIY. ODAT. KATOK. OKUDA: "Influence of surface modifications to titanium on antibacterial activity in vitro", BIOMATERIALS, vol. 22, 2001, pages 2043 - 2048, XP004245923, DOI: 10.1016/S0142-9612(00)00392-6 |
YOSHINARI, M. ET AL.: "Influence of surface modifications to titanuim on antibacterial activity in vitro", BIOMATERIALS, vol. 22, 2001, pages 2043 - 2048, XP004245923, DOI: 10.1016/S0142-9612(00)00392-6 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022130981A1 (en) * | 2020-12-15 | 2022-06-23 | 京セラ株式会社 | Composite material, method for manufacturing same, and biological implant |
Also Published As
Publication number | Publication date |
---|---|
JP7155259B2 (en) | 2022-10-18 |
EP3804768A1 (en) | 2021-04-14 |
CN112188903A (en) | 2021-01-05 |
AU2019279208A1 (en) | 2021-01-28 |
AU2019279208B2 (en) | 2022-01-27 |
JP2023015032A (en) | 2023-01-31 |
JP2024028859A (en) | 2024-03-05 |
EP3804768A4 (en) | 2022-03-09 |
JP7400049B2 (en) | 2023-12-18 |
US20210196862A1 (en) | 2021-07-01 |
JPWO2019230871A1 (en) | 2021-06-17 |
EP3804768A9 (en) | 2022-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hussein et al. | Mechanical, in-vitro corrosion, and tribological characteristics of TiN coating produced by cathodic arc physical vapor deposition on Ti20Nb13Zr alloy for biomedical applications | |
Resnik et al. | Strategies for improving antimicrobial properties of stainless steel | |
Luo et al. | Surface characteristics, corrosion behavior, and antibacterial property of Ag-implanted NiTi alloy | |
JP2024028859A (en) | Composite material and bioimplant | |
Liu et al. | Improved corrosion resistance and antibacterial properties of composite arch-wires by N-doped TiO 2 coating | |
Jeong et al. | Bacterial attachment on titanium surfaces is dependent on topography and chemical changes induced by nonthermal atmospheric pressure plasma | |
Fuentes et al. | Advanced surface treatments on titanium and titanium alloys focused on electrochemical and physical technologies for biomedical applications | |
Sun et al. | Biphasic calcium phosphates/tantalum pentoxide hybrid layer and its effects on corrosion resistance and biocompatibility of titanium surface for orthopedic implant applications | |
Chen et al. | Antibacterial ability and biocompatibility of fluorinated titanium by plasma-based surface modification | |
Jarosz et al. | Anodization of titanium alloys for biomedical applications | |
Xue et al. | Antibacterial properties and cytocompatibility of Ti-20Zr-10Nb-4Ta alloy surface with Ag microparticles by laser treatment | |
Fathi et al. | Tantalum, niobium and titanium coatings for biocompa improvement of dental implants | |
Sun et al. | Bioactive (Si, O, N)/(Ti, O, N)/Ti composite coating on NiTi shape memory alloy for enhanced wear and corrosion performance | |
Hong et al. | Improved bonding strength between TiO2 film and Ti substrate by microarc oxidation | |
US20090187253A1 (en) | Method of making a coated medical bone implant and a medical bone implant made thereof | |
RO129460A2 (en) | Carbides of high entropy alloys as thin layers, for coating articular endoprostheses | |
Saad et al. | Application of PVD coatings in medical implantology for enhanced performance, biocompatibility, and quality of life | |
JP6580964B2 (en) | Titanium materials and bioimplants | |
EP3195825B1 (en) | Dental implant | |
RO130173A2 (en) | Biocompatible materials based on high-entropy alloy carbides, for coating mobile couplings of articular endoprostheses and medical instruments | |
WO2022130981A1 (en) | Composite material, method for manufacturing same, and biological implant | |
Rokosz et al. | SEM and EDS studies of selected porous coatings obtained on titanium by Plasma Electrolytic Oxidation | |
Billah et al. | A review on surface modification of NiTinol for biomedical applications | |
Karlagina et al. | In Vitro Study of Ti Implants with Laser-functionalized Surface | |
Souza et al. | Surface Modification of the Ti25Ta25Nb3Sn Alloy and its Influence on The Cell and Bacteria Adhesion-In Vitro Studies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19811092 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2020522583 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2019811092 Country of ref document: EP Effective date: 20210111 |
|
ENP | Entry into the national phase |
Ref document number: 2019279208 Country of ref document: AU Date of ref document: 20190530 Kind code of ref document: A |